Litigation prevented HRSA Office of Pharmacy Affairs Director Rear Adm. Krista Pedley from addressing most of the hottest 340B issues in her talk today to 340B Coalition winter conference attendees.

Muted by Litigation, Pedley Avoids Hottest 340B Topics But Provides Some Nuggets

The U.S. Health Resources and Services Administration (HRSA) is “ramping up” its work with the Biden administration “and bringing forth the key issues and concerns of” the 340B program, Rear Adm. Krista Pedley, the program’s director, said today in a speech to program stakeholders attending the online 340B Coalition winter conference. Beyond that, though, Pedley could say little to say about the hottest topics in 340B, due to current litigation.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content

*Sign up for news summaries and alerts from 340B Report